Discover 363 paid clinical trials in Quebec City, Quebec. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 363
Effects of a Supervised Rehabilitation Program on Disease Severity in Spastic Ataxias
for
Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay,
Location: Quebec, Saguenay, Montreal
Sponsor: Laval University
Sex: All
Age: 16+
Code: NCT06261424
Recruiting
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
for
Oligometastatic Prostate Cancer (OMPC)
Location: Quebec, Montreal, Ottawa, Boston MA, Syracuse NY,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT05939414
Phase3, Recruiting
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Evaluation of Intraocular Pressure Following a Vitreoretinal Surgery Using Goldmann Applanation Tonometry, Icare and Accupen
for
Intraocular Pressure
Location: Quebec
Sponsor: CHU de Quebec-Universite Laval
Sex: All
Age: 18+
Code: NCT06522867
Recruiting
Autologous Cultured Corneal Epithelium (CECA) for the Treatment of Limbal Stem Cell Deficiency
for
Limbal Stem Cell Deficiency
Location: Quebec, Montreal, Toronto
Sponsor: CHU de Quebec-Universite Laval
Sex: All
Age: 1+
Code: NCT01756365
Recruiting
Feasibility and Acceptability of Collecting Sociodemographic Data in CCTG Trials
for
Cancer
Location: Quebec, Ottawa, Saint John, Kingston, Toronto, Regina,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT07390435
Recruiting
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
for
B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma,
Location: Quebec, Boston MA, New York NY, Toronto, Buffalo NY,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT05006716
Phase1, Phase2, Recruiting
Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)
A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
for
Advanced Malignant Tumors
Location: Quebec, Hackensack NJ, Germantown TN, Vancouver
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06764771
Phase1, Recruiting
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
for
Bladder Cancer
Location: Quebec, Boston MA, New York NY, Morristown NJ, Toronto,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07419295
Phase3, Recruiting
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
for
Chronic Lymphocytic Leukemia
Location: Quebec, Sherbrooke, Montreal, Boston MA, New York NY,